References

1. 1.
   Department of Medical Administration，National Health Commission of the People's Republic of China.Guideline for diagnosis and treatment of primary liver cancer （2024 edition）［J］.Chin J Magn Reson Imaging，2024，15（6）：1-18.
2. 2.
   BRAY F，LAVERSANNE M，SUNG H，et al.Global cancer statistics 2022：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin，2024，74（3）：229-263.
3. 3.
   JA M，LM K，CB S，et al.Diagnosis，staging，and management of hepatocellular carcinoma：2018 practice guidance by the American association for the study of liver diseases［J］.Hepatology，2018，68（2）：723-750.
4. 4.
   ZHOU J，SUN H，WANG Z，et al.Guidelines for the diagnosis and treatment of hepatocellular carcinoma （2019 edition）［J］.Liver Cancer，2020，9（6）：682-720.
5. 5.
   YE S W，ZAHANG W.Professor ZHANG Wei's diagnostic and therapeutic approach for primary liver cancer［J］.Chin J Integr Tradit West Med Liver Dis，2023，33（2）：160-162.
6. 6.
   CASADEI-GARDINI A，SCARTOZZI M，TADA T，et al.Lenvatinib versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma：An inverse probability of treatment weighting analysis［J］.Liver Int，2021，41（6）：1389-1397.
7. 7.
   SEN R，BALTIMORE D.Inducibility of kappa immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism［J］.Cell，1986，47（6）：921-928.
8. 8.
   WAN F，LENARDO M J.The nuclear signaling of NF-κB：Current knowledge，new insights，and future perspectives［J］.Cell Res，2010，20（1）：24-33.
9. 9.
   CUI Y，CAO X P.Research advances in nuclear factor-κB［J］.J North Sichuan Med Coll，2014，29（5）：510-513.
10. 10.
    LI M，LIU P，WANG B，et al.Inhibition of nuclear factor kappa B as a therapeutic target for lung cancer［J］.Altern Ther Health Med，2022，28（1）：44-51.
11. 11.
    LIU Z，WU F G，ZOU J T，et al.Correlation between nuclear factor-kappa B and bone metastasis of lung cancer［J］.Pract J Cancer，2021，36（12）：1950-1952.
12. 12.
    GENG X，CHI W C，LIN X Y，et al.Mechanism of NF-κB signaling pathway in regulating lung cancer and intervention of traditional Chinese medicine：A review［J］.Chin J Exp Tradit Med Form，2023，29（16）：207-216.
13. 13.
    MULERO M C，HUXFORD T，GHOSH G.NF-κB，IκB，and IKK：Integral components of immune system signaling［J］.Adv Exp Med Biol，2019，1172：207-226.
14. 14.
    PERKINS N D.The diverse and complex roles of NF-κB subunits in cancer［J］.Nat Rev Cancer，2012，12（2）：121-132.
15. 15.
    DURAND J K，ZHANG Q，BALDWIN A S.Roles for the IKK-related kinases TBK1 and IKKε in cancer［J］.Cells，2018，7（9）：139.
16. 16.
    WEN J，HUANG Z，WEI Y，et al.Hsa-microRNA-27b-3p inhibits hepatocellular carcinoma progression by inactivating transforming growth factor-activated kinase-binding protein 3/nuclear factor kappa B signalling［J］.Cell Mol Biol Lett，2022，27（1）：79.
17. 17.
    LI H P，DAI A J，LI Y H，et al.Expression of nuclear factor-κB and nucleolar protein 14 in primary hepatocellular carcinoma and their relationship with clinical characteristics［J］.Oncol Prog，2022，20（10）：1028-1030，1034.
18. 18.
    RAPE M.Ubiquitylation at the crossroads of development and disease［J］.Nat Rev Mol Cell Biol，2018，19（1）：59-70.
19. 19.
    YU H，LIN L，ZHANG Z，et al.Targeting NF-κB pathway for the therapy of diseases：Mechanism and clinical study［J］.Signal Transduct Target Ther，2020，5（1）：209.
20. 20.
    SHENG X，YOU Q，ZHU H，et al.Enterohemorrhagic E.coli effector NleL disrupts host NF-κB signaling by targeting multiple host proteins［J］.J Mol Cell Biol，2020，12（4）：318-321.
21. 21.
    SENFTLEBEN U，CAO Y，XIAO G，et al.Activation by IKKalpha of a second，evolutionary conserved，NF-kappa B signaling pathway［J］.Science，2001，293（5534）：1495-1499.
22. 22.
    VALLABHAPURAPU S，KARIN M.Regulation and function of NF-kappaB transcription factors in the immune system［J］.Annu Rev Immunol，2009，27：693-733.
23. 23.
    SU L J，REN Y C，CHEN Z，et al.Ginsenoside Rb₁ improves brain，lung，and intestinal barrier damage in middle cerebral artery occlusion/reperfusion （MCAO/R） micevia the PPARγ signaling pathway［J］.Chin J Nat Med，2022，20（8）：561-571.
24. 24.
    HARHAJ E W，DIXIT V M.Deubiquitinases in the regulation of NF-κB signaling［J］.Cell Res，2011，21（1）：22-39.
25. 25.
    KEARNS J D，BASAK S，WERNER S L，et al.Ikappa Bepsilon provides negative feedback to control NF-kappaB oscillations，signaling dynamics，and inflammatory gene expression［J］.J Cell Biol，2006，173（5）：659-664.
26. 26.
    SHEMBADE N，HARHAJ N S，PARVATIYAR K，et al.The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20［J］.Nat Immunol，2008，9（3）：254-262.
27. 27.
    HYMOWITZ S G，WERTZ I E.A20：From ubiquitin editing to tumour suppression［J］.Nat Rev Cancer，2010，10（5）：332-341.
28. 28.
    HITOTSUMATSU O，AHMAD R C，TAVARES R，et al.The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals［J］.Immunity，2008，28（3）：381-390.
29. 29.
    XIA G，QI F，YANG J H，et al.Expression of nuclear factor-kappa B p65 in hepatocellular carcinoma and its significance［J］.Clin J Clin Hepatol，2017，33（12）：2342-2345.
30. 30.
    CHIANG I T，LIU Y C，WANG W H，et al.Sorafenib inhibits TPA-induced MMP-9 and VEGF expression via suppression of ERK/NF-κB pathway in hepatocellular carcinoma cells［J］.In Vivo，2012，26（4）：671-681.
31. 31.
    LI J B，KE S D，HU S M.Effect of berberine on TNF-α-induced VEGF expression via NF-κB signaling pathway［J］.J Huazhong Univ Sci Technol Med Sci，2014，43（4）：386-390.
32. 32.
    GRETEN F R，GRIVENNIKOV S I.Inflammation and Cancer：Triggers，mechanisms，and consequences［J］.Immunity，2019，51（1）：27-41.
33. 33.
    O’NEIL B H，BŮZKOVÁ P，FARRAH H，et al.Expression of nuclear factor-kappa B family proteins in hepatocellular carcinomas［J］.Oncology，2007，72（1-2）：97-104.
34. 34.
    XIA Y H，ZHOU J，CHANG Y H，et al.Expression of NF-κB and Caspase-3 and its significance in hepatocellular carcinomas［J］.China J Mod Med，2012，22（3）：26-29.
35. 35.
    YANG Z H，ZHANG Y，LIU H J，et al.Research progress of the role of NF-κB in invasion and metastasis of primary hepatocellular carcinoma［J］.Clin Res Pract，2018，3（31）：197-198.
36. 36.
    WANG Z，YING Y M，LI K Q，et al.Marsdeniae tenacissima extract-induced growth inhibition and apoptosis in hepatoma carcinoma cells is mediated through the p53/nuclear factor-κB signaling pathway［J］.Exp Ther Med，2017，14（3）：2477-2484.
37. 37.
    JIANG J X，LI N，KANG R X，et al.Study on the improvement of tumor inflammation in H22 mice with hepatocellular carcinoma through IL-6/STAT3/NF-κB sgnaling pathway in the total saponins from Marsdenia Tenacissima［J］.J Liaoning Univ Tradit Chin Med，2024，26（11）：30-35.
38. 38.
    LI M，JIANG C Z，CHEN J T，et al.Formononetin inhibits tumor immune escape of hepatocarcinoma-bearing mice through TLR4/NF-κB pathway［J］.Chin J Immunol，2023，39（9）：1872-1877.
39. 39.
    OU S，LIU W L，DENG X J.Acute and chronic toxicity studies of wild Asian ginseng fruit extract［J］.Strait Pharm J，2019，31（6）：19-23.
40. 40.
    LI Y，LI H M，QI Y，et al.Exploring the anti-hepatoma effect of fermentation liquor of fresh fruit of Phytolacca acinosa Roxb.in vitro based on PI3K/Akt/NF-κB signaling pathway［J］.Chin J Mod Appl Pharm，2025，42（5）：697-705.
41. 41.
    WANG B，WANG H，ZHAO Q，et al.Matrine induces hepatocellular carcinoma apoptosis and represses EMT and stemness through microRNA-299-3p/PGAM1 axis［J］.Growth Factors，2022，40（5-6）：200-211.
42. 42.
    WANG W，LI M，SI H，et al.Network pharmacology and integrated molecular docking study on the mechanism of the therapeutic effect of Fangfeng decoction in osteoarthritis［J］.Curr Pharm Des，2023，29（5）：379-392.
43. 43.
    XIE W Y，LU Y B，GUO X M，et al.Exploring the mechanism of Sophora Flavescens mediated NF-κB pathway against hepatocellular based on target network and molecular docking［J］.Heilongjiang Med J，2024，37（4）：745-750.
44. 44.
    FAN Y，XUE H，ZHENG H.Systemic therapy for hepatocellular carcinoma：Current updates and outlook［J］.J Hepatocell Carcinoma，2022，30（9）：233-263.
45. 45.
    FENG Q Z.Baicalein combined with luteolin against liver cancer by inhibiting the EGFR/ERK/NF-κB signaling pathway［D］.Hefei：Anhui Medical University，2024.
46. 46.
    XIE X，XIE S，XIE C，et al.Pristimerin attenuates cell proliferation of uveal melanoma cells by inhibiting insulin-like growth factor-1 receptor and its downstream pathways［J］.J Cell Mol Med，2019，23（11）：7545-7553.
47. 47.
    FU L N，XING B Z，CHEN Y，et al.Influence of pristimerin on autophagy and apoptosis in hepatocellular carcinoma cells by regulating Akt/NF-κB/mTOR signaling pathway［J］.Chin J Anat，2024，47（5）：404-409.
48. 48.
    LI C，DU L M，SUN Q，et al.The effect of atractylodes macrocephalaon polysaccharide on stem cell-like properties of hepatoma cells，epithelial-mesenchymal transition and phosphorylation of Akt/NF-κB pathway［J］.Chin Clin Oncol，2024，29（8）：735-739.
49. 49.
    ZHANG X，LI J M，YANG F F，et al.The effect of hydroxysafflor yellow A on NF-κB signaling pathway in transplanted hepatocellula carcinoma in mice［J］.J Binzhou Med Coll，2016，39（2）：89-91，95.
50. 50.
    CHANG C，ZHU Y Q，MEI J J，et al.Involvement of mitochondrial pathway in NCTD-induced cytotoxicity in human HepG2 cells［J］.J Exp Clin Cancer Res，2010，29（1）：145.
51. 51.
    WANG D.The role of nuclear factor-kappa B in the norcantharidininduced apoptosis of liver cancer cell SMMC-7721［D］.Shijiazhuang：Hebei Medical University，2013.
52. 52.
    HU J X，XI X T，WANG X M，et al.Mechanism of Humifuse euphorbia in regulating tumor angiogenesis by NF-κB / VEGF signal pathway［J］.Chin J Exp Tradit Med Form，2018，24（23）：165-170.
53. 53.
    HU Q，ZHU D Y，TAN X M，et al.Effect of drug-containing serum of Clerodendrum bungei on liver cancer cells through PI3K/Akt signaling pathway［J］.Chin J Exp Tradit Med Form，2019，25（22）：28-33.
54. 54.
    WANG C L，WEN X D.Transcriptome analysis of ethanol extract of Akebia trifoliate （Thunb.） Koidz on cell proliferation inhibitory functions and apoptosis promotion in human liver cells［J］.Chin J Comp Med，2024，34（8）：60-71.
55. 55.
    WANG R，SHAO X，YANG J，et al.Ginkgo biloba extract mechanism inhibits hepatocellular carcinoma through the nuclear factor-κB/p53 signaling pathway［J］.J Environ Pathol Toxicol Oncol，2020，39（2）：179-189.
56. 56.
    DUAN Y F，ZHANG Z R，FAN J L，et al.Studies on the effects of Ginsenosides Rh₂ and CK on the malignant behavior of ovarian cancer cells and on ovarian cancer cell-macrophage crosstalk［J］.J Chin Med Pharmacol，2024，52（12）：18-24.
57. 57.
    ZHANG J，MA X，FAN D.Ginsenoside CK inhibits hypoxia-induced epithelial-mesenchymal transformation through the HIF-1α/NF-κB feedback pathway in hepatocellular carcinoma［J］.Foods，2021，10（6）：1195.
58. 58.
    LI M，ZHANG M，ZHANG Z L，et al.Induction of apoptosis by berberine in hepatocellular carcinoma HepG2 cells via downregulation of NF-κB［J］.Oncol Res，2017，25（2）：233-239.
59. 59.
    YAO F，ZHANG L，JIANG G，et al.Osthole attenuates angiogenesis in an orthotopic mouse model of hepatocellular carcinoma via the downregulation of nuclear factor-κB and vascular endothelial growth factor［J］.Oncol Lett，2018，16（4）：4471-4479.
60. 60.
    ZHAO X，ZHAO P J，GAO J L，et al.Protective effects of Fuzheng Huajie decoction on liver tissues in a rat model of diethylnitrosamine-induced hepatocellular carcinoma［J］.Zhejiang J Integr Tradit Chin West Med，2023，33（4）：313-317.
61. 61.
    DU F，DONG L J.Mechanism of Astragalus polysaccharide in inhibiting proliferation of human hepatocellular carcinoma cells［J］.West China J Pharm Sci，2020，35（4）：402-406.
62. 62.
    CHEN C，ZHANG J F，FANG X.The study on mechanism of action of Herba Hedyotis diffusae in treating liver-cancer［J］.Henan Tradit Chin Med，2018，38（1）：67-71.
63. 63.
    YANG P W，ZHU J X，CHEN X J，et al.Mechanism of Scutellariae Barbatae Herba and Hedyotis diffusa Willd.regulating Wnt/β-catenin axis［J］.Pharmacol Clin Chin Mater Med，2024，40（12）：48-54.
64. 64.
    YANG J W，ZHANG Y.Research progress on anti-tumor effect of extracted parts and active components of Ranunculus ternatus［J］.Drug Eval Res，2021，44（2）：446-451.
65. 65.
    WANG B，CHENG Y F，WU J，et al.Effects of polysaccharides from roots of Radix Tetrastigma on proliferation，apoptosis，migration and invasion of HepG2 cells［J］.J Jinan Univ：Nat Sci Med Ed，2020，41（5）：444-454.
66. 66.
    YANG Y P，DUAN Y Q，LIANG J Q，et al.Investigation of the tumor suppression effect and immune function of Shenqi Yiliu Decoction combined with Cisplatin on H22 liver cancer tumor-bearing mice based on HMGB1/TLR4/NF-κB pathway［J］.Mod Tradit Chin Med Mater Med World Sci Technol，2023，25（7）：2365-2372.
67. 67.
    ZENG Q T，MA C L，LI H L，et al.Inhibitory effect of Shenqi Yiliu decoction combined with Cisplatin on H22 tumor-bearing mice and its impact on immune function［J］.Gansu Sci and Technol，2018，34（6）：127-130.
68. 68.
    HUANG C L，LIU H Z.Effect of Shenqi Yiliu decoction combined with neoadjuvant chemotherapy on immune function and prognosis［J］.China Contemp Med，2021，27（17）：139-140.
69. 69.
    SUN J L，WEN B，YANG X M，et al.Mechanism research of regulation of proliferation and metastasis of hepatoma cells Hep3B by Biejiajian pill based on PI3K/Akt/GSK-3β signaling pathway［J］.China J Tradit Chin Med Pharm，2021，36（3）：1361-1365.
70. 70.
    ZHONG X D.Mechanism of Biejia Jian wan regulating epithelial-mesenchymal transition of hepatocellular carcinoma cells through the NF-κB signaling pathway［D］.Guangzhou：Southern Medical University，2022.
71. 71.
    CHEN Y，HU H，ZHANG S J，et al.Effect of the Sijunzi decoction on the T lymphocyte and NK cell of the hepatocellular［J］.Chin J Integr Tradit West Med Liver Dis，2017，27（1）：8-10.
72. 72.
    DE QUEIROZ R M，CARVALHO E，DIAS W B.O-GlcNAcylation：The sweet side of the cancer［J］.Frontiers in Oncology，2014，4：132.
73. 73.
    LI M Z，FANG Z Q，ZHANG W F，et al.Mechanism of Si Junzitang in inhibiting hepatocellular carcinoma progression through regulating O-GlcNAcylation of NF-κB p65 in paracancerous tissues［J］.Chin J Exp Tradit Med Form，2024，30（15）：21-28.